Search company, investor...


Founded Year



Series A | Alive

About RNACure

RNACure develops a one-step mRNA Drug Discovery Platform made from mRNA synthesis. It provides early discovery for new targets, and a rapid expanding pipeline.

Headquarters Location

Shanghai, Shanghai,


Missing: RNACure's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: RNACure's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing RNACure

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

RNACure is included in 1 Expert Collection, including Early-Stage Pharma Market Map.


Early-Stage Pharma Market Map

82 items

RNACure Frequently Asked Questions (FAQ)

  • When was RNACure founded?

    RNACure was founded in 2019.

  • Where is RNACure's headquarters?

    RNACure's headquarters is located at Shanghai.

  • What is RNACure's latest funding round?

    RNACure's latest funding round is Series A.

  • Who are the investors of RNACure?

    Investors of RNACure include 3E Bioventures, Ligang Capital, LYZZ Capital, Zhonghuan Capital, Shenghui Jingchen Investment and 3 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.